Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting the upper and lower motor neurons causing progressive weakness. It eventually involves the diaphragm which leads to respiratory paralysis and subsequently death. Phrenic nerve (PN) conduction studies and diaphragm ultrasound has been studied and correlated with pulmonary function tests in ALS patients. However, PN ultrasonography has not been employed in ALS. This study aims to sonographically evaluate the morphologic appearance of the PN of ALS patients. Thirty-eight ALS patients and 28 normal controls referred to the neurophysiology laboratory of two institutions were retrospectively included in the study. Baseline demographic and clinical variables such as disease duration, ALS Functional Rating Scale-Revised score, and ALS region of onset were collected. Ultrasound was used to evaluate the PN cross-sectional area (CSA) of ALS and control subjects. The mean PN CSA of ALS patients were 1.08 ± 0.39 mm on the right and 1.02 ± 0.34 mm on the left. The PN CSA of ALS patients were significantly decreased compared to controls (p value < 0.00001). The PN CSA of ALS patients was not correlated to any of the demographic and clinical parameters tested. This study demonstrates that ALS patients have a smaller PN size compared to controls using ultrasonography.
Hinweise
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ALS
Amyotrophic lateral sclerosis
ALSFRS-R
ALS Functional Rating Scale-Revised
CSA
Cross-sectional area
DExp
Right hemidiaphragm width at expiration;
Dins
Right hemidiaphragm width during maximal inspiration
DRest
Right hemidiaphragm width at rest
HD
Hemidiaphragm
PFT
Pulmonary function test
PN
Phrenic nerve
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder predominantly affecting the upper and lower motor neurons causing progressive weakness and muscle wasting [1]. Weakness eventually involving the diaphragm leads to respiratory paralysis and subsequently death in ALS [1, 2]. As a surrogate marker for respiratory function, diaphragm ultrasound has been employed in ALS in several studies [3‐6]. Diaphragm thickness was observed to be reduced in ALS and it is correlated with measures of respiratory function [2‐5]. Phrenic nerve (PN) motor conduction studies have also been used to evaluate the respiratory function and have been observed to detect latent respiratory dysfunction as well as predict survival in ALS [7, 8].
Recently, peripheral nerve ultrasound has been investigated in ALS for diagnostic and monitoring purposes [2]. Measurements of nerve cross-sectional area (CSA) and diameter have been employed and decreased nerve caliber was consistently reported in different nerves [2, 9‐12]. However, no consensus has yet been achieved as to which nerves are specific and sensitive for ALS diagnosis and disease progression monitoring [2].
Anzeige
In a postmortem study of 11 ALS patients, the majority of large myelinated fibers were lost with some acute axonal degeneration seen in the PN [13]. To demonstrate in vivo changes, this study aims to determine if a pure motor nerve such as the phrenic nerve would sonographically show evidence of decreased nerve caliber similar to other peripheral nerves in ALS patients.
Methods
Subjects with a final diagnosis of ALS based on the updated Awaji criteria were identified from the list of patients referred to the neurophysiology laboratories of Tokushima University Hospital and Vihara Hananosato Hospital from 2018 to 2019 [14]. Patients with complete data on ultrasonographic PN CSA measurements were retrospectively included. Patients were seen on an outpatient basis and without overt respiratory distress. Baseline demographic data including age, sex, ALS disease duration, ALS region of onset, and most recent ALS Functional Rating Scale-Revised (ALSFRS-R) score were obtained. Normal control CSA values of the PN were obtained from the hospital staff and residents of an elderly facility which did not exhibit any neurological symptoms.
Ultrasonography was done by two experienced authors, NT and HY. All normal controls were done by NT and ALS patients were done by NT and HY in a non-randomized non-blinded manner. To account for other sources of measurement error, the patients were divided into two cohorts based on the ultrasonographer and the demographic and clinical characteristics were compared. There was a significant difference in terms of age, disease duration and ALSFRS-R score between the two groups. However, the PN CSA measurements done by the two ultrasonographers were similar between the two groups. With multivariate analysis, it can be noted that age, disease duration and ALSFRS-R scores have F-statistic values less than 5, which is considered very low, hence, the authors believe that these have little relationship with PN CSA measurements. Nevertheless, these are considered confounding variables in this study.
LOGIQ e Premium device with a 12-MHz linear array transducer was used for sonographic analysis. All ultrasonographic analyses were done in the supine position. Axial images of the PN were obtained by locating the scalene muscles at the interscalene triangle. The PN is measured as it crosses over the anterior scalene muscle, coursing towards the internal jugular vein and common carotid artery on the medial side of the neck [15]. The CSA of the PN was measured by manually tracing the area within the nerve’s hyperechoic rim using the trace function on the machine. The right hemidiaphragm (HD) was visualized by placing the probe on the right intercostal space between the anterior axillary line and the mid-axillary line. The HD was visibly outlined by two parallel lines, the pleural line on top and the peritoneal line below. The HD width was measured by taking the distance from the pleural line to the peritoneal line. Measurements were made during relaxed position, labeled as diaphragm width at rest (DRest), during maximal inspiration, labeled as inspiratory width (DIns), and during maximal expiration, labeled as expiratory width (DExp). The thickening ratio was calculated as the ratio of DIns to DExp [3, 16].
Anzeige
This study was approved by the institutional review board of two institutions and the subjects gave written informed consent at the time of testing.
Statistical analysis
Statistical analysis was conducted by one of the authors. R statistical software (R Foundation for Statistical Computing, Vienna, Austria) was used for all statistical analyses and statistical significance was set at p < 0.05. Descriptive statistics were used for the characterization of the sample. Multivariate analysis was done to determine the correlation of the demographic variables to the PN CSA. Linear regression analysis using the Kendall correlation coefficient (tau) was used to correlate PN CSAs with clinical parameters. Computation for correlation was likewise done on the right PN CSA and right HD measurements. Wilcoxon signed-rank test or Kruskal–Wallis rank-sum test were used where appropriate to check for the difference in paired and unpaired samples.
Results
There were 38 ALS patients and 28 control subjects included in the study. According to the updated Awaji criteria 9 patients were classified as definite ALS, 14 were probable ALS, 14 were probable-laboratory supported ALS, and 1 was possible ALS. Based on the initial region of onset, 24 were upper limb-onset, 5 were lower limb-onset, and 9 were bulbar-onset. The mean disease duration from onset to evaluation was 26.16 months (Interquartile range 7 months, 37 months) and the mean ALSFRS-R score was 38.41 ± 6.87.
Table 1 shows the demographic characteristics of the subjects. Both groups were similar in terms of age, sex, height, weight, and body mass index (BMI). Although no significant difference was seen between the demographic variables of the two groups, it can be observed that ALS patients have a higher mean age and height and have more male subjects. A multivariate analysis of the demographic variables showed that in normal controls, age (p < 0.001) and height (p < 0.001) were directly correlated to the right PN. However, the adjusted R2 for the regression model is only 0.37, suggesting that age and height contribute to only 37% of the variability in the measurements of the right PN CSA. Additionally, the F-statistic is only 9.06, which is quite small to explain a relationship between age and height and the right PN CSA. The left PN of normal subjects and both the right and left PN of ALS patients were not correlated to the demographic characteristics.
Table 1
Demographic characteristics of the control subjects and ALS patients
Variable
Control
ALS
p valuea
Number
28
38
Age years, mean ± SD (range, years)
59.61 ± 24.45 (19–93)
64.71 ± 12.76 (31–87)
0.53
Sex (M:F)
10:18
23:15
0.08b
Height cm, mean ± SD (range, cm)
157.75 ± 7.36 (140–171)
161.50 ± 8.76 (138.6–178)
0.08
Weight kg, mean ± SD (range, kg)
56.89 ± 13.26 (35–96)
56.41 ± 11.15 (34.4–81.5)
0.98
BMI kg/m2, mean ± SD (range, kg/m2)
22.72 ± 4.40 (16.23–36.58)
21.52 ± 3.19 (14.17–26.89)
0.54
BMI Body Mass Index
aWilcoxon signed-rank test
bΧ2 test for equality of proportions
Figure 1 shows the representative sonographic images of the PN in a control and an ALS subject. The mean and standard deviation values for the PN CSA and different HD width measurements are seen in Table 2. The mean right and left PN CSA values of the ALS patients were significantly different from the normal controls. For the HD measurements, it must be noted that some data were missing. Only a total of 18 patients had DExp and DIns measurements while 20 patients had DRest measurements.
Fig. 1
The PN, marked by the solid white arrows, are seen here as it courses above the anterior scalene muscle coursing towards the common carotid artery. a The PN CSA of the normal subject was 1.4 mm2. b The PN CSA was 0.6 mm2 for the ALS patient. AS anterior scalene muscle, CCA common carotid artery, IJV internal jugular vein, SCM sternocleidomastoid
Table 2
Clinical characteristics of the control subjects and ALS patients
Variable
Control
ALS
p valuea
Number
28
38
Right PN CSA mm2, mean ± SD (range, mm2)
1.62 ± 0.45 (1.010–2.840)
1.08 ± 0.39 (0.52–2.05)
< 0.00001
Left PN CSA mm2, mean ± SD (range, mm2)
1.39 ± 0.31 (1.010–2.150)
1.02 ± 0.34 (0.45–1.69)
< 0.00001
DRest mm, mean ± SD (range, mm)
N/A
1.34 ± 0.38 (n = 20) (0.5–2.0)
DExp mm, mean ± SD (range, mm)
N/A
1.21 ± 0.37 (n = 18) (0.5–2.1)
DIns mm, mean ± SD (range, mm)
N/A
2.03 ± 0.77 (n = 18) (0.6–4.0)
Thickening ratio
N/A
1.66 ± 0.27 (n = 18) (1.2–2.2)
DRest diaphragm width at rest, DExp expiratory diaphragm width, DIns inspiratory diaphragm width, thickening ratio DIns/Dexp
aWilcoxon signed-rank test
×
The right HD at the rest of an ALS patient is illustrated in Fig. 2. No correlation was seen between the clinical variables and PN CSAs. Both the right and left PN CSAs were not correlated to the disease parameters tested – disease duration, ALSFRS-R score, and ALS region of onset. The right PN CSA was not correlated to DExp, DIns, DRest or thickening ration of the right HD.
Fig. 2
Representative image of the right HD of an ALS patient taken at rest. The crosshairs mark the pleural line (top) and the peritoneal line (bottom) with the DRest measuring 0.9 mm
×
The right PN CSA was significantly larger than the left PN CSA among normal controls only (p < 0.01). The right and left PN CSA were not significantly different from each other in ALS patients. Additionally, both the right and left PN CSA were directly correlated to each other in both normal and ALS subjects (p < 0.05). The correlation plot is shown in Fig. 3.
Fig. 3
The correlation plots between the right and left PN CSA for both the normal controls and ALS subjects. R2 adjusted R value
×
Discussion
This study demonstrated that the PN of ALS patients were significantly smaller than normal controls. As reported in ultrasound studies of other peripheral nerves, progressive motor neuron loss resulting in axonal degeneration is implicated as the cause of smaller nerve caliber observed in ALS [2, 9, 10]. Congruent to our findings, a postmortem study of the PN of 11 ALS patients showed uniform loss of two-thirds of large myelinated axons from the proximal to the distal region [13]. Apart from axonal loss, significant distal axonal atrophy of the PN was seen when compared with controls [13].
Anzeige
The multivariate analysis of the demographic variables showed that age and height were correlated to the right PN CSA of normal controls. In a sonographic analysis of healthy subjects, age was seen to be indirectly correlated to PN CSA but not correlated to height [17]. The correlation with age was attributed by the authors to age-related degeneration of myelinated nerve fibers [17]. However, the PN CSA of ALS subjects were not correlated to age despite having an older population cohort. The age and height of ALS patients were larger than those of normal controls, but this was not statistically significant. The authors attribute the finding of a correlation between age and right PN CSA of normal controls to have a minimal effect due to the low R2 and F-statistic values.
The right PN CSA of normal controls were significantly larger than the left PN CSA. A study among 20 healthy volunteers showed a larger right PN CSA compared to the left but the difference was likewise not significant [18]. The same trend was not seen among ALS subjects where the right was not significantly different from the left PN CSA. Oxidative damage has been suggested as the cause of axonal dysfunction and degradation in ALS [19]. Oxidative stess affecting diffuse cellular processes may explain the diffuse degeneration of both the right and left PN.
Bilateral PN CSA was not correlated to any of the clinical variables. There was no correlation between PN CSA and disease duration. This may suggest that the PN morphology may be affected even at an early time in the disease process. Studies on animal models of motor neuron disease have shown that distal axonal degeneration may precede symptom onset and motor neuron death [19]. However, this pathologic sequence has not been proven in human ALS cases. If the PN indeed shows changes even at an early disease course, a longitudinal study sonographically evaluating the PN may be helpful in this situation. The PN CSA were also not correlated to ALSFRS-R score and initial region of onset. Nerve conduction studies of the PN were not correlated to ALS region of onset, signifying that the loss of motor units was comparable whether the region of onset was bulbar or spinal [20]. The ALSFRS-R score was likewise not correlated to PN conduction studies [7]. These studies along with our study may suggest that the PN CSA and the PN conduction studies are not reliable markers to show changes in relation to the ALSFRS-R score or ALS region of onset.
The mean DExp was 1.21 ± 0.37 mm while the thickening ratio was 1.66 ± 0.27. Unfortunately, HD measurements were not taken from the control group hence statistical comparisons could not be made in this study. A published study has set the reference value of right HD thickness at normal end-expiration at 0.33 ± 0.1 cm or 3.3 mm, and thickening ratio at 1.8 ± 0.5 cm (18 mm) [16]. The mean diaphragm measurements seen in our set of ALS patients is lower by more than half compared to the normal subjects in the abovementioned study, however, a statistical comparison cannot be made. Previous studies have demonstrated that ALS patients have decreased diaphragm thickness or diaphragm thickening ratios compared to controls [3, 4]. More importantly, the diaphragm ultrasound thickening ratio was correlated with respiratory function tests such as forced vital capacity, nasal inspiratory pressure during sniff and maximal voluntary ventilation [5]. These previous reports suggest the use of diaphragm ultrasound in assessing pulmonary function in ALS patients [3, 4].
Anzeige
The limitation of this study is its retrospective design. Measurement bias may have been present due to the observational nature of the study and the lack of evaluation of interrater reliability. The difference observed between the PN CSA of the controls and the ALS patients may have been affected by various confounders during the measurement process. Future research employing a blinded measurement of the PN CSA with inter-rater reliability measurements may help provide stronger proof of PN CSA changes in ALS patients. Additionally, the phrenic nerve ultrasound was not correlated with pulmonary function tests (PFT). Diaphragm ultrasound and PN conduction studies have been demonstrated to be well correlated to PFT in prior studies [3‐8]. Hence, future studies may evaluate the value of PN ultrasound to PFT and assess respiratory dysfunction more directly in ALS.
Conclusion
In conclusion, this study demonstrates that ALS patients have a smaller PN size compared to controls using ultrasonography.
Acknowledgments
The authors would like to extend their gratitude to Akiko Miyake and Dr. Masaya Oda for helping us collect the data and Dr. Peter Franz San Martin for his invaluable assistance in data analysis.
Compliance with ethical standards
Conflict of interest
None of the authors have any conflict of interest.
Anzeige
Ethical approval
This study was conducted in accordance with the Declaration of Helsinki for biomedical research involving human subjects and was approved by the respective institutional ethics board panel.
Informed consent
Informed consent was obtained from all participants.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.
Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.
Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.
Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.
Update Neurologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
